19 people die in Delaware with COVID-19 listed as the underlying cause in week ending September 4

 -
-
0Comments

There were 19 deaths with COVID-19 listed as the underlying cause reported in Delaware during the week ending September 4, a 11.8 percent increase over the previous week, according to The Centers for Disease Control and Prevention.

In the week ending September 4, there were 192 deaths in the state. 19.8 percent of deaths were caused by heart disease, 19.3 percent were from cancer and 19.8 percent were from COVID-19. Additionally, 8.9 percent of deaths were from Alzheimer’s disease and dementia.

Studies show doctors and medical examiners may underreport Alzheimer’s disease and dementia-related conditions as the underlying cause of death on death certificates, according to the National Institute on Aging.

Once infected, older adults with dementia are likely to develop a more severe and dangerous illness. The diseases which make an older adult more vulnerable to COVID-19 are age-associated chronic conditions, according to the Bright Focus Foundation.

Delaware top 10 causes of death in week ending September 4

Cause of Death Number of Deaths 2021-09-04 Number of Deaths 2021-08-28
Heart disease 38 36
Malignant neoplasms (cancerous tumor) 37 37
COVID-19 (underlying cause) 19 17
COVID-19 (multiple cause) 19 18
Cerebrovascular diseases 13 < 10
Diabetes mellitus 11 < 10
Influenza and pneumonia < 10 < 10
Nephritis, nephrotic syndrome and nephrosis < 10 < 10
Alzheimer’s disease < 10 < 10
Chronic lower respiratory diseases < 10 11

Delaware Dementia deaths in week ending September 4
Cause of Death Number of Deaths 2021-09-04 Number of Deaths 2021-08-28
Alzheimer disease and dementia 17 17


Related

Benjamin L. Wallace, U.S. Attorney for the District of Delaware

Sussex County man pleads guilty to transporting minor for sexual activity

A Sussex County man has pleaded guilty to transporting a minor across state lines for criminal sexual activity after meeting her online through Snapchat. He faces up to life imprisonment with sentencing set for August.

Benjamin L. Wallace, U.S. Attorney for the District of Delaware

Former Delaware physician agrees to pay $180,000 in genetic testing fraud case

Dr. Shayasta S. Mufti has agreed to pay $180,000 after being accused of ordering unnecessary genetic tests for over 100 Medicare patients without proper examinations or consultations between April and November 2019 in Delaware. Authorities say such actions waste taxpayer money and threaten healthcare program integrity.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA reports lowest Q1 inspection count for biologics companies in Delaware

During the first quarter of 2026, the U.S. Food and Drug Administration (FDA) carried out an inspection at a Biologics company in Delaware.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from First State Times.